SUMO-1 Modification of PIASy, an E3 Ligase, Is Necessary for PIASy-Dependent Activation of Tcf-4

REFERENCES

• Abmayr, S. M., and J. L. Workman. 1989. Preparation of nuclear and cytoplasmic extracts from mammalian cells, p. 12.1.1–12.1.9. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Wiley, New York, N.Y.
   Google Scholar
• Azuma, Y., A. Arnaoutov, and M. Dasso. 2003. SUMO-2/3 regulates topoisomerase II in mitosis. J. Cell Biol. 163:477–487.
   PubMed Web of Science ®Google Scholar
• Bienz, M., and H. Clevers. 2000. Linking colorectal cancer to Wnt signaling. Cell 103:311–320.
   PubMed Web of Science ®Google Scholar
• Dobreva, G., J. Dambacher, and R. Grosschedl. 2003. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin μ gene expression. Genes Dev. 17:3048–3061.
   PubMed Web of Science ®Google Scholar
• Fey, E. G., K. M. Wan, and S. Penman. 1984. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J. Cell Biol. 98:1973–1984.
   PubMed Web of Science ®Google Scholar
• Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P. P. Pandolfi, H. Will, C. Schneider, and G. Del Sal. 2000. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19:6185–6195.
   PubMedGoogle Scholar
• Gill, G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms. Genes Dev. 18:2046–2059.
   PubMed Web of Science ®Google Scholar
• Gong, L., S. Millas, G. G. Maul, and E. T. Yeh. 2000. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275:3355–3359.
   PubMed Web of Science ®Google Scholar
• Hino, S.-I., T. Michiue, M. Asashima, and A. Kikuchi. 2003. Casein kinase Iε enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of β-catenin. J. Biol. Chem. 278:14066–14073.
   PubMed Web of Science ®Google Scholar
• Hochstrasser, M. 2000. Evolution and function of ubiquitin-like protein-conjugation systems. Nat. Cell Biol. 2:E153–E157.
   PubMedGoogle Scholar
• Hofmann, T. G., A. Moller, H. Sirma, H. Zentgraf, Y. Taya, W. Droge, H. Will, and M. L. Schmitz. 2002. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4:1–10.
   PubMed Web of Science ®Google Scholar
• Hurlstone, A., and H. Clevers. 2002. T-cell factors: turn-ons and turn-offs. EMBO J. 21:2303–2311.
   PubMedGoogle Scholar
• Ikeda, S., S. Kishida, H. Yamamoto, H. Murai, S. Koyama, and A. Kikuchi. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 17:1371–1384.
   PubMed Web of Science ®Google Scholar
• Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053–3058.
   PubMedGoogle Scholar
• Kadoya, T., S. Kishida, A. Fukui, T. Hinoi, T. Michiue, M. Asashima, and A. Kikuchi. 2000. Inhibition of Wnt signaling pathway by a novel Axin-binding protein. J. Biol. Chem. 275:37030–37037.
   PubMedGoogle Scholar
• Kadoya, T., H. Yamamoto, T. Suzuki, A. Yukita, A. Fukui, T. Michiue, T. Asahara, K. Tanaka, M. Asashima, and A. Kikuchi. 2002. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of β-catenin. Mol. Cell. Biol. 22:3803–3819.
   PubMedGoogle Scholar
• Kagey, M. H., T. A. Melhuish, and D. Wotton. 2003. The Polycomb protein Pc2 is a SUMO E3. Cell 113:127–137.
   PubMed Web of Science ®Google Scholar
• Kikuchi, A. 1999. Roles of Axin in the Wnt signalling pathway. Cell. Signal 11:777–788.
   PubMed Web of Science ®Google Scholar
• Kishida, M., S. Koyama, S. Kishida, K. Matsubara, S. Nakashima, K. Higano, R. Takada, S. Takada, and A. Kikuchi. 1999. Axin prevents Wnt-3a-induced accumulation of β-catenin. Oncogene 18:979–985.
   PubMed Web of Science ®Google Scholar
• Kishida, S., H. Yamamoto, S.-I. Hino, S. Ikeda, M. Kishida, and A. Kikuchi. 1999. DIX domains of Dvl and Axin are necessary for protein interactions and their ability to regulate β-catenin stability. Mol. Cell. Biol. 19:4414–4422.
   PubMed Web of Science ®Google Scholar
• Kishida, S., H. Yamamoto, S. Ikeda, M. Kishida, I. Sakamoto, S. Koyama, and A. Kikuchi. 1998. Axin, a negative regulator of the Wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J. Biol. Chem. 273:10823–10826.
   PubMed Web of Science ®Google Scholar
• Korinek, V., N. Barker, P. J. Morin, D. van Wichen, R. de Weger, K. W. Kinzler, B. Vogelstein, and H. Clevers. 1997. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma. Science 275:1784–1787.
   PubMed Web of Science ®Google Scholar
• Kotaja, N., U. Karvonen, O. A. Janne, and J. J. Palvimo. 2002. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:5222–5234.
   PubMed Web of Science ®Google Scholar
• Li, S. J., and M. Hochstrasser. 1999. A new protease required for cell-cycle progression in yeast. Nature 398:246–251.
   PubMed Web of Science ®Google Scholar
• Liu, B., J. Liao, X. Rao, S. A. Kushner, C. D. Chung, D. D. Chang, and K. Shuai. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95:10626–10631.
   PubMed Web of Science ®Google Scholar
• Matunis, M. J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1457–1470.
   PubMed Web of Science ®Google Scholar
• Melchior, F., M. Schergaut, and A. Pichler. 2003. SUMO: ligases, isopeptidases, and nuclear pores. Trends Biochem. Sci. 28:612–618.
   PubMed Web of Science ®Google Scholar
• Müller, S., A. Ledl, and D. Schmidt. 2004. SUMO: a regulator of gene expression and genome integrity. Oncogene 23:1998–2008.
   PubMed Web of Science ®Google Scholar
• Müller, S., M. J. Matunis, and A. Dejean. 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:61–70.
   PubMed Web of Science ®Google Scholar
• Pichler, A., A. Gast, J. Seeler, A. Dejean, and F. Melchior. 2002. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108:109–120.
   PubMed Web of Science ®Google Scholar
• Roth, W., C. Sustmann, M. Kieslinger, A. Gilmozzi, D. Irmer, E. Kremmer, C. Turck, and R. Grosschedl. 2004. PIASy-deficient mice display modest defects in IFN and Wnt signaling. J. Immunol. 173:6189–6199.
   PubMedGoogle Scholar
• Sachdev, S., L. Bruhn, H. Sieber, A. Pichler, F. Melchior, and R. Grosschedl. 2001. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:3088–3103.
   PubMed Web of Science ®Google Scholar
• Saitoh, H., and J. Hinchey. 2000. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275:6252–6258.
   PubMed Web of Science ®Google Scholar
• Saitoh, H., D. B. Sparrow, T. Shiomi, R. T. Pu, T. Nishimoto, T. J. Mohun, and M. Dasso. 1998. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8:121–124.
   PubMedGoogle Scholar
• Salomoni, P., and P. P. Pandolfi. 2002. The role of PML in tumor suppression. Cell 108:165–170.
   PubMed Web of Science ®Google Scholar
• Sampson, D. A., M. Wang, and M. J. Matunis. 2001. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276:21664–21669.
   PubMed Web of Science ®Google Scholar
• Schmidt, D., and S. Müller. 2003. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60:2561–2574.
   PubMed Web of Science ®Google Scholar
• Schwartz, D. C., and M. Hochstrasser. 2003. A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem. Sci. 28:321–328.
   PubMedGoogle Scholar
• Sewalt, R. G., M. G. Gunster, J. van der Vlag, D. P. Satijin, and A. P. Otte. 1999. C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Mol. Cell. Biol. 19:777–787.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y., A. Toh-E, and Y. Kikuchi. 2003. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro. J. Biochem. 133:415–422.
   PubMedGoogle Scholar
• Tetsu, O., and F. McCormick. 1999. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426.
   PubMed Web of Science ®Google Scholar
• Wodarz, A., and R. Nusse. 1998. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14:59–88.
   PubMed Web of Science ®Google Scholar
• Yamamoto, H., M. Ihara, Y. Matsuura, and A. Kikuchi. 2003. Sumoylation is involved in β-catenin-dependent activation of Tcf-4. EMBO J. 22:2047–2059.
   PubMedGoogle Scholar
• Yeh, E. T., L. Gong, and T. Kamitani. 2000. Ubiquitin-like proteins: new wines in new bottles. Gene 248:1–14.
   PubMed Web of Science ®Google Scholar